iShares China Large-Cap ETF (FXI)

Key Updates

FXI declined 2.02% since the June 3 report to $34.87, extending YTD losses to -8.94% and marking a continuation of the volatile trading pattern established since mid-May. The selloff coincides with a significant regulatory development: China's securities regulator imposed severe penalties on three major brokerages for illegally facilitating mainland investors' access to overseas stocks, requiring liquidation of mainland accounts within two years. This crackdown represents Beijing's intensifying effort to control capital outflows and redirect domestic investment toward Chinese markets. Despite this negative development, underlying fundamentals show improvement with the stock-yuan correlation reaching a three-year high driven by renewed foreign investor confidence in China's AI and technology sectors, with April recording $1.3 billion in net foreign inflows after March outflows.

Current Trend

FXI remains in a confirmed downtrend across all timeframes: -1.71% (1-day), -0.53% (5-day), -7.00% (1-month), -12.60% (6-month), and -8.94% YTD. The ETF has failed to establish sustained support above the $35.50-$36.00 range tested during the late May/early June recovery attempts. Current price of $34.87 represents a breakdown below this technical support zone, with the 6-month decline of -12.60% indicating persistent selling pressure. The recent volatility pattern—alternating between sharp declines and brief recoveries—reflects conflicting forces: positive diplomatic developments and AI sector momentum versus regulatory tightening and capital control concerns. The ETF is trading near its lowest levels in the measured period, suggesting investor caution remains elevated despite improved U.S.-China relations.

Investment Thesis

The investment case for FXI centers on China's economic stabilization, attractive valuations at 11x 2027 forecast earnings (half of U.S. multiples), and the country's emerging position as an AI and technology innovation hub rather than merely a manufacturing base. China's $20 trillion economy has moved past its property crisis with record trade surpluses of $1.2 trillion in 2025, while major corporations like AstraZeneca commit $15 billion through 2030. The technology sector demonstrates robust growth with Baidu reporting 49% AI revenue surge and Zhipu achieving 132% revenue growth in 2025. Expected earnings growth of 15% matches U.S. levels at significantly lower valuations. Improved U.S.-China diplomatic relations following the Trump-Xi summit, with potential tariff reductions on $30 billion in goods, creates a more favorable operating environment. However, the thesis faces headwinds from Beijing's capital control intensification and foreign direct investment remaining at $80 billion—significantly below the $344 billion 2021 peak.

Thesis Status

The investment thesis faces a critical inflection point. While fundamental catalysts remain intact—improved geopolitics, strong AI sector growth, and attractive valuations—the regulatory crackdown on cross-border trading platforms introduces a material new risk factor not previously considered. Beijing's enforcement actions against Futu, Tiger Brokers, and Longbridge signal intensifying capital controls that could limit foreign participation and market liquidity. This directly contradicts the positive momentum from $1.22 billion in China ETF inflows following the Trump-Xi meeting. The thesis remains viable for nimble investors who can navigate regulatory volatility, but the risk-reward profile has deteriorated. The 40-day stock-yuan correlation reaching three-year highs creates additional complexity for the People's Bank of China in balancing growth support with exchange-rate stability, potentially limiting policy flexibility.

Key Drivers

Regulatory Crackdown: China's securities regulator penalized three brokerages for illegally offering mainland investors overseas stock access, with Futu and Up Fintech experiencing 28% and 25% declines respectively. This represents Beijing's attempt to redirect the 171 trillion yuan in household savings toward domestic markets rather than U.S. technology stocks.

AI Sector Momentum: UBS adopted a bullish stance on Chinese tech stocks citing China's expanding AI ecosystem, with Baidu's AI business revenue surging 49% to 13.6 billion yuan and Zhipu posting 132% revenue growth in 2025. This technological advancement supports the long-term investment case despite near-term volatility.

Foreign Capital Flows: Foreign investors returned as net buyers in April with $1.3 billion in inflows, reversing March outflows, while the CSI 300 Index gained 10% and the yuan strengthened 1.8% against the dollar over two months. This created a reinforcing feedback loop increasing demand for the yuan.

Valuation Opportunity: Chinese equities trade at 11 times 2027 forecast earnings—roughly half U.S. multiples—while expected earnings growth of 15% matches American levels, according to Goldman Sachs data. Global equity fund allocations to Chinese assets rose from 1.4% in early 2024 to 1.8% by February 2025.

Geopolitical Stabilization: Morgan Stanley raised price targets through Q2 2027 projecting 8-12% upside across major benchmarks, citing improved earnings and China's strengthening position in global upstream supply chains following the Trump-Xi summit discussions on potential tariff reductions.

Technical Analysis

FXI broke below critical support at $35.50 established during the late May recovery attempt, currently trading at $34.87 with no immediate technical support visible until the $33.00-$34.00 zone. The price action shows a pattern of lower highs and lower lows since the April peak, with each recovery attempt failing to sustain momentum above resistance. The 6-month decline of -12.60% exceeds the YTD loss of -8.94%, indicating accelerating selling pressure in recent months. Volume patterns suggest distribution during rallies, with the most recent 2.56% gain on June 2 immediately reversed. The ETF trades approximately 11% below its level from the October highs referenced in earlier reports. Key resistance now sits at $35.50-$36.00 (former support), while downside targets extend to $33.00 if current support fails. The technical structure remains bearish with no signs of trend reversal despite positive fundamental developments.

Bull Case

• AI Ecosystem Expansion: Chinese tech companies demonstrate exceptional AI growth with Baidu's AI revenue surging 49% to 13.6 billion yuan and Zhipu achieving 132% revenue growth in 2025, positioning China as a global AI innovation hub beyond manufacturing, with UBS highlighting reduced geopolitical risks allowing markets to focus on fundamentals.
• Valuation Discount: Chinese equities trade at 11x 2027 forecast earnings—half of U.S. multiples—while maintaining 15% expected earnings growth matching American levels, creating significant upside potential as global allocations increased from 1.4% to 1.8% with major corporate commitments like AstraZeneca's $15 billion investment through 2030.
• Foreign Capital Inflows: Foreign investors returned as net buyers in April with $1.3 billion in inflows after March outflows, with the CSI 300 Index gaining 10% and yuan strengthening 1.8%, creating a reinforcing feedback loop where equity inflows increase yuan demand and tighten offshore liquidity.
• Improved Geopolitics: Morgan Stanley projects 8-12% upside through Q2 2027 across major Chinese indexes following the Trump-Xi summit, with potential tariff reductions on $30 billion in goods and China's strengthening position in global upstream supply chains supporting earnings improvement.
• Policy Support: China's 15th Five-Year Plan emphasizes technology innovation and green energy sectors with government support for semiconductor localization, AI, and biotech development, creating structural tailwinds for companies positioned in high-end power and upstream supply chains.

Bear Case

• Capital Control Intensification: China's securities regulator imposed severe penalties on Futu, Tiger Brokers, and Longbridge requiring liquidation of mainland accounts within two years, with Futu and Up Fintech declining 28% and 25% respectively, signaling Beijing's determination to restrict capital outflows and limit foreign market access despite only $176 billion in official overseas investment quotas.
• Technical Breakdown: FXI declined 12.60% over six months and 8.94% YTD, breaking below $35.50 support to $34.87 with no immediate technical floor until $33.00-$34.00, establishing a pattern of lower highs and lower lows with each recovery attempt failing to sustain momentum above resistance levels.
• Persistent FDI Weakness: Foreign direct investment of $80 billion in 2025 remains significantly below the $344 billion peak in 2021, with private equity investors prioritizing liquid, easily-exitable positions due to lingering concerns about regulatory unpredictability and capital repatriation challenges.
• Policy Coordination Risk: The three-year high correlation between stocks and yuan creates a policy challenge for the People's Bank of China in balancing growth support with exchange-rate stability, as foreign equity inflows tighten offshore yuan liquidity and raise Hong Kong borrowing costs to highest levels since February.
• Economic Data Weakness: Recent April economic data missed expectations across consumption, industrial output, and investment growth, indicating underlying economic momentum remains fragile despite stabilization from the property crisis, with the regulatory crackdown potentially further dampening domestic investor sentiment and market liquidity.